Eye Clinic Sulzbach, Knappschaft Hospital Saar.
Klaus Heimann Eye Research Institute, An der Klinik 10, Sulzbach.
Curr Opin Ophthalmol. 2021 May 1;32(3):288-293. doi: 10.1097/ICU.0000000000000745.
After removing the native vitreous during vitreoretinal surgery, an adequate substitute is required to ensure homeostasis of the eye. Current clinically used endotamponades (silicone oil, gases, semifluorinated alkanes) are effective in promoting retinal reattachment, but lead to complications such as emulsification, prolonged inflammation, blurred vision, raised intraocular pressure, cataract formation or the need for revision surgery. The aim of this review is to provide an update on novel vitreous substitutes with a focus on polymer-based systems.
Polymeric hydrogels provide favourable properties such as high water content, optical transparency, suitable refractive indices and densities, adjustable rheological properties, injectability, biocompatibility and their ability to tamponade the retina via viscosity and swelling pressure, comparable to the native human vitreous body. Here, vitreous replacement strategies can be divided into chemically or physically crosslinked hydrogel systems that are applied as preformed or in-situ gelling matrices.
Several hydrogel-based vitreous substitutes have already been positively evaluated in preclinical tests and have the potential to enter the clinical phase soon.
在玻璃体视网膜手术后去除天然玻璃体时,需要有足够的替代品来确保眼睛的内环境稳定。目前临床上使用的眼内填充物(硅油、气体、半氟化烷烃)在促进视网膜复位方面是有效的,但会导致乳化、炎症持续时间延长、视力模糊、眼内压升高、白内障形成或需要再次手术等并发症。本文的目的是提供一种关于新型玻璃体替代品的最新综述,重点介绍基于聚合物的系统。
聚合物水凝胶具有许多有利的特性,如高含水量、光学透明度、合适的折射率和密度、可调节的流变学特性、可注射性、生物相容性以及通过粘度和溶胀压力来填塞视网膜的能力,与天然人玻璃体相当。在这里,玻璃体替代策略可以分为化学或物理交联的水凝胶系统,它们作为预成型或原位凝胶基质应用。
几种基于水凝胶的玻璃体替代品已经在临床前试验中得到了积极的评价,并且有可能很快进入临床阶段。